Evidence map›Paper›PMID 31160955›Full record

ArticleChemical science2019

Chiral diversification through the assembly of achiral phenylacetylene macrocycles with a two-fold bridge.

Ryo Katoono, Keiichi Kusaka, Yuki Saito, Kazuki Sakamoto, Takanori Suzuki

Abstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Folding-controlled assembly ofChemical science · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ryo KatoonoDepartment of Chemistry , Faculty of Science , Hokkaido University , Sapporo 060-0810 , Japan . Email: katoono@sci.hokudai.ac.jp ; ; Tel: +81 11 706-3396.ORCID 0000-0001-7462-3735
Keiichi KusakaDepartment of Chemistry , Faculty of Science , Hokkaido University , Sapporo 060-0810 , Japan . Email: katoono@sci.hokudai.ac.jp ; ; Tel: +81 11 706-3396.
Yuki SaitoDepartment of Chemistry , Faculty of Science , Hokkaido University , Sapporo 060-0810 , Japan . Email: katoono@sci.hokudai.ac.jp ; ; Tel: +81 11 706-3396.
Kazuki SakamotoDepartment of Chemistry , Faculty of Science , Hokkaido University , Sapporo 060-0810 , Japan . Email: katoono@sci.hokudai.ac.jp ; ; Tel: +81 11 706-3396.
Takanori SuzukiDepartment of Chemistry , Faculty of Science , Hokkaido University , Sapporo 060-0810 , Japan . Email: katoono@sci.hokudai.ac.jp ; ; Tel: +81 11 706-3396.ORCID 0000-0002-1230-2044

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We demonstrate so-called "chiral diversification", which is a design strategy to create multiple chiral molecules through the assembly and double-bridging of achiral components. We used phenylacetylene macrocycles (PAMs) as an achiral element. In a molecule, two achiral rings of [6]PAM are stacked one above the other, or bound to each other mechanically. As an alternative, a single enlarged ring of [12]PAM was also assumed to be a doubled form of [6]PAM. In any case, one or two ring(s) are doubly-bridged by covalent bonds to exert chirality. Through intramolecular two-bond formation, these multiple chiral molecules were obtained as a set of products in one reaction. The dynamic chirality generated in molecules with either two helically-stacked rings of [6]PAM or a single helically-folded ring of [12]PAM was characterized by induced Cotton effects with the aid of an external chiral source. Thus, a chiral structure based on [12]PAM could be demonstrated as the first success. Alternatively, enantiomeric separation was achieved for molecules with two interlocked rings of [6]PAM to show remarkable chiroptical properties.

Identifiers

PMID31160955
PMCPMC6510063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.